Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

AstraZeneca Pharma Ltd.

BSE: 506820 | NSE: ASTRAZEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE203A01020 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Feb 27, 15:40
8850.00 -0.60 (-0.01%)
Volume
AVERAGE VOLUME
5-Day
177
10-Day
260
30-Day
360
163
  • Prev. Close

    8850.60

  • Open Price

    8838.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 27, 15:44
8849.00 0.00 (0.00%)
Volume
AVERAGE VOLUME
5-Day
4,426
10-Day
4,352
30-Day
7,064
3,330
  • Prev. Close

    8849.00

  • Open Price

    8805.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    8849.00 (25)

Financials

Cash Flow of AstraZeneca Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 113.97 72.67 43.80 35.50 5.76  
Net CashFlow From Operating Activities 87.42 54.98 8.79 38.10 56.99  
Net Cash Used In Investing Activities -170.80 4.28 -9.36 0.25 -3.61  
Net Cash Used From Financing Activities -6.36 0.00 0.00 0.00 -0.51  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -89.74 59.26 -0.57 38.35 52.87  
Cash And Cash Equivalents Begin of Year 173.24 113.98 114.55 76.20 23.33  
Cash And Cash Equivalents End Of Year 83.50 173.24 113.98 114.55 76.20  
Source : Dion Global Solutions Limited
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026